Despite all of the advances in our understanding of the pathophysiology of inflammatory
bowel disease (IBD), we still do not know its cause. Some of the most recently available data …

Although the aetiology of inflammatory bowel disease (IBD) remains unknown, the
pathogenesis is gradually being unravelled, seeming to be the result of a combination of …

Inflammatory bowel disease (IBD), most commonly referring to Crohn's disease and
ulcerative colitis, is a chronic and disabling condition with an increasing incidence in …

Ulcerative colitis (UC) and Crohn's disease (CD), the primary constituents of inflammatory
bowel disease (IBD), are precipitated by a complex interaction of environmental, genetic …

Over the last 2 decades, novel therapies targeting several immune pathways have been
developed for the treatment of patients with inflammatory bowel disease (IBD). Although anti …

Inflammatory bowel disease, including its 2 entities ulcerative colitis and Crohn's disease, is
a chronic medical condition characterized by the destructive inflammation of the intestinal …

Over the past decade a major hypothesis has emerged for the etiopathogenesis of
inflammatory bowel disease (IBD). This hypothesis proposes that IBD represents a …

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal
tract with a multifactorial pathophysiology. Full comprehension of IBD pathology is still out of …

The etiology of inflammatory bowel disease (IBD) has not yet been clarified and
immunosuppressive agents which nonspecifically reduce inflammation and immunity have …

Ulcerative colitis (UC) and Crohn's disease (CD), collectively referred to as inflammatory
bowel disease (IBD), present with differing histologic and cytokine profiles. While the precise …